Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
77.91
-1.14 (-1.44%)
May 29, 2026, 4:00 PM EDT - Market closed
Arrowhead Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 622.01 | 829.45 | 3.55 | 240.74 | 243.23 | 138.29 | |
Revenue Growth (YoY) | 14.09% | 23258.15% | -98.52% | -1.03% | 75.89% | 57.16% |
Gross Profit | 622.01 | 829.45 | 3.55 | 240.74 | 243.23 | 138.29 |
Selling, General & Admin | 156.39 | 123.94 | 98.76 | 92.55 | 124.43 | 80.98 |
Research & Development | 687.51 | 607.16 | 505.87 | 353.19 | 297.31 | 206.34 |
Total Operating Expenses | 843.9 | 731.1 | 604.63 | 445.74 | 421.74 | 287.32 |
Operating Income | -221.9 | 98.35 | -601.08 | -205 | -178.51 | -149.04 |
Interest Income | 46.63 | 37.29 | 22.72 | 15.3 | 5.03 | 6.12 |
Interest Expense | -92.43 | -89.36 | -32.35 | -18.33 | - | - |
Other Non-Operating Income (Expense) | 15.43 | 5.26 | -1.75 | 1.54 | 0.77 | 2.07 |
Total Non-Operating Income (Expense) | -33.14 | -46.81 | -11.38 | -1.49 | 5.8 | 8.19 |
Pretax Income | -252.26 | 51.53 | -612.46 | -206.49 | -172.71 | -140.85 |
Provision for Income Taxes | 19.6 | 21.42 | -2.77 | 2.78 | 3.79 | 0 |
Net Income | -300.91 | -1.63 | -599.49 | -205.28 | -176.06 | -140.85 |
Minority Interest in Earnings | 29.05 | 31.75 | -10.2 | -4 | -0.43 | - |
Net Income to Common | -300.91 | -1.63 | -599.49 | -205.28 | -176.06 | -140.85 |
Shares Outstanding (Basic) | 139 | 134 | 120 | 107 | 105 | 104 |
Shares Outstanding (Diluted) | 139 | 134 | 120 | 107 | 105 | 104 |
Shares Change (YoY) | 9.70% | 11.67% | 12.21% | 1.26% | 1.62% | 3.00% |
EPS (Basic) | -2.15 | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
EPS (Diluted) | -2.15 | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
Shares Outstanding | 140.57 | 135.7 | 124.38 | 107.31 | 105.96 | 104.33 |
Free Cash Flow | -50.87 | 156.89 | -604.32 | -330.63 | -188.91 | 147.75 |
Free Cash Flow Per Share | -0.37 | 1.17 | -5.05 | -3.10 | -1.79 | 1.42 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -35.67% | 11.86% | -16927.10% | -85.16% | -73.39% | -107.77% |
Profit Margin | -43.71% | 3.63% | -17169.60% | -86.93% | -72.56% | -101.85% |
FCF Margin | -8.18% | 18.91% | -17018.30% | -137.34% | -77.67% | 106.84% |
EBITDA | -196.52 | 122.27 | -582.49 | -192.51 | -168.09 | -140.77 |
EBITDA Margin | -31.59% | 14.74% | -16403.40% | -79.97% | -69.11% | -101.79% |
EBIT | -221.9 | 98.35 | -601.08 | -205 | -178.51 | -149.04 |
EBIT Margin | -35.67% | 11.86% | -16927.10% | -85.16% | -73.39% | -107.77% |
Effective Tax Rate | -7.77% | 41.56% | 0.45% | -1.35% | -2.19% | -0.00% |